Location: Home
  • search
  • go
  • Relate News
  • 3/6/2024CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • 3/6/2024US Senate Committee Approves Bill That Could Restrict Chinese Biotech
  • 3/6/2024Biopharma Delegates Advocate for Policy Reforms During China's Two Ses...
  • 3/6/2024Shanghai's Progressive Health Insurance Initiatives: Paving the Way fo...
  • 3/6/2024China's Medical App Revolution Spearheaded by Ping An Good Doctor with...
  • 3/5/2024NMPA Announces Package Insert Revision of Synovitis Formulations
  • 3/5/20242024 Chinese Government Work Report Highlights with Emphasis on Health...
  • 3/5/2024China Biopharma Tracker – January 2024 (PharmaNJ)
  • 3/4/2024IQVIA: China Closes Gap with the U.S. in New Drug Approvals
  • 3/3/2024Haihe and Taiho Enter Exclusive License Deal for Anticancer Gumarontin...
  • 3/3/2024Mabwell Out-Licenses Ex-China Rights of Rare Disease Drug to Disc Medi...
  • 3/3/2024Bitterroot Bio and Biotheus Enter Research Partnership to Develop Bisp...
  • 3/3/2024AstraZeneca Signs $475 Million Deal for Innovative Drug Facility in Wu...
  • 3/3/2024China to Expand Basic Medical Insurance Coverage for Children
  • 3/1/2024Recent Official Changes and Executive Moves
  • 3/1/2024Drug R&D and Product Registration News Digest February 2024 (3)
  • 3/1/2024Financial-related Company News Digest (February 2024)
  • 3/1/2024Lab Monkey Prices Plunge in China as Drug Research Slows (FT)
  • 2/29/2024Review of Chinese Retail Pharmacy Market (Offline and Online) 2013-202...
  • 2/29/2024CDE Issues the Technical Guidelines for Clinical Trial of Growth Hormo...
  • 2/28/2024AstraZeneca Chooses Shanghai as Fifth Global Strategic Center, Reinfor...
  • 2/28/2024NHSA Study Affirms Generic Metformin Effectiveness in China's Bulk Buy...
  • 2/28/2024BeiGene Defies Biotech Winter with Workforce Expansion and Sales Surge...
  • 2/28/2024China Strengthens Healthcare Infrastructure with Over 18,000 Medical C...
  • 2/27/2024NHSA Releases A List of Pharma Companies with Serious Bad Faith Practi...
  • 2/26/2024Nhwa Pharma Licenses China Commericialization Rights of Teva's AUSTEDO...
  • 2/26/2024Despite Challenges, German MNCs Plans Increased Investments in China
  • 2/26/2024CDE Introduces a Legal Document Submission Module on the Patent Inform...
  • 2/26/2024Chinese Pharma R&D Investment Grew by Nearly 20% in 2023
  • 2/26/2024Chinese Researchers Made Breakthrough in Biosynthesis of Anticancer Pa...
  • Page:15/718 Total number of articles:21530: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group